Literature DB >> 30232220

Heterozygosity of Chaperone Grp78 Reduces Intestinal Stem Cell Regeneration Potential and Protects against Adenoma Formation.

Jooske F van Lidth de Jeude1, Claudia N Spaan1, Bartolomeus J Meijer1, Wouter L Smit1, Tanya T D Soeratram1, Mattheus C B Wielenga1, B Florien Westendorp1, Amy S Lee2, Sander Meisner1, Jacqueline L M Vermeulen1, Manon E Wildenberg1, Gijs R van den Brink1, Vanesa Muncan1, Jarom Heijmans3,4.   

Abstract

Deletion of endoplasmic reticulum resident chaperone Grp78 results in activation of the unfolded protein response and causes rapid depletion of the entire intestinal epithelium. Whether modest reduction of Grp78 may affect stem cell fate without compromising intestinal integrity remains unknown. Here, we employ a model of epithelial-specific, heterozygous Grp78 deletion by use of VillinCreERT2-Rosa26ZsGreen/LacZ-Grp78+/fl mice and organoids. We examine models of irradiation and tumorigenesis, both in vitro and in vivo Although we observed no phenotypic changes in Grp78 heterozygous mice, Grp78 heterozygous organoid growth was markedly reduced. Irradiation of Grp78 heterozygous mice resulted in less frequent regeneration of crypts compared with nonrecombined (wild-type) mice, exposing reduced capacity for self-renewal upon genotoxic insult. We crossed mice to Apc-mutant animals for adenoma studies and found that adenomagenesis in Apc heterozygous-Grp78 heterozygous mice was reduced compared with Apc heterozygous controls (1.43 vs. 3.33; P < 0.01). In conclusion, epithelium-specific Grp78 heterozygosity compromises epithelial fitness under conditions requiring expansive growth such as adenomagenesis or regeneration after γ-irradiation. These results suggest that Grp78 may be a therapeutic target in prevention of intestinal neoplasms without affecting normal tissue.Significance: Heterozygous disruption of chaperone protein Grp78 reduces tissue regeneration and expansive growth and protects from tumor formation without affecting intestinal homeostasis. Cancer Res; 78(21); 6098-106. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30232220      PMCID: PMC8272399          DOI: 10.1158/0008-5472.CAN-17-3600

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

1.  BiP and immunoglobulin light chain cooperate to control the folding of heavy chain and ensure the fidelity of immunoglobulin assembly.

Authors:  Y K Lee; J W Brewer; R Hellman; L M Hendershot
Journal:  Mol Biol Cell       Date:  1999-07       Impact factor: 4.138

2.  Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response.

Authors:  A Bertolotti; Y Zhang; L M Hendershot; H P Harding; D Ron
Journal:  Nat Cell Biol       Date:  2000-06       Impact factor: 28.824

3.  Grp78 heterozygosity regulates chaperone balance in exocrine pancreas with differential response to cerulein-induced acute pancreatitis.

Authors:  Risheng Ye; Olga A Mareninova; Ernesto Barron; Miao Wang; David R Hinton; Stephen J Pandol; Amy S Lee
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

Review 4.  The intestinal crypt, a prototype stem cell compartment.

Authors:  Hans Clevers
Journal:  Cell       Date:  2013-07-18       Impact factor: 41.582

Review 5.  Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential.

Authors:  Amy S Lee
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

6.  Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium.

Authors:  Toshiro Sato; Daniel E Stange; Marc Ferrante; Robert G J Vries; Johan H Van Es; Stieneke Van den Brink; Winan J Van Houdt; Apollo Pronk; Joost Van Gorp; Peter D Siersema; Hans Clevers
Journal:  Gastroenterology       Date:  2011-09-02       Impact factor: 22.682

7.  GRP78 haploinsufficiency suppresses acinar-to-ductal metaplasia, signaling, and mutant Kras-driven pancreatic tumorigenesis in mice.

Authors:  Jieli Shen; Dat P Ha; Genyuan Zhu; Daisy F Rangel; Agnieszka Kobielak; Parkash S Gill; Susan Groshen; Louis Dubeau; Amy S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

8.  A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis.

Authors:  Dezheng Dong; Christopher Stapleton; Biquan Luo; Shigang Xiong; Wei Ye; Yi Zhang; Niyati Jhaveri; Genyuan Zhu; Risheng Ye; Zhi Liu; Kevin W Bruhn; Noah Craft; Susan Groshen; Florence M Hofman; Amy S Lee
Journal:  Cancer Res       Date:  2011-04-05       Impact factor: 12.701

Review 9.  ER chaperones in mammalian development and human diseases.

Authors:  Min Ni; Amy S Lee
Journal:  FEBS Lett       Date:  2007-04-25       Impact factor: 4.124

10.  Tissue-specific and inducible Cre-mediated recombination in the gut epithelium.

Authors:  Fatima el Marjou; Klaus-Peter Janssen; Benny Hung-Junn Chang; Mei Li; Valérie Hindie; Lawrence Chan; Daniel Louvard; Pierre Chambon; Daniel Metzger; Sylvie Robine
Journal:  Genesis       Date:  2004-07       Impact factor: 2.487

View more
  4 in total

1.  The concerted action of oncogenic driver mutations directs global translation in intestinal epithelial cells.

Authors:  Wouter Smit; Jarom Heijmans
Journal:  Mol Cell Oncol       Date:  2021-05-19

2.  Expression of UPR effector proteins ATF6 and XBP1 reduce colorectal cancer cell proliferation and stemness by activating PERK signaling.

Authors:  Claudia N Spaan; Wouter L Smit; Jooske F van Lidth de Jeude; Bartolomeus J Meijer; Vanesa Muncan; Gijs R van den Brink; Jarom Heijmans
Journal:  Cell Death Dis       Date:  2019-06-21       Impact factor: 8.469

Review 3.  ER Stress and the UPR in Shaping Intestinal Tissue Homeostasis and Immunity.

Authors:  Olivia I Coleman; Dirk Haller
Journal:  Front Immunol       Date:  2019-12-04       Impact factor: 7.561

4.  Omega-3 Fatty Acid-Enriched Fish Oil and Selenium Combination Modulates Endoplasmic Reticulum Stress Response Elements and Reverses Acquired Gefitinib Resistance in HCC827 Lung Adenocarcinoma Cells.

Authors:  Chien-Huang Liao; Yu-Tien Tzeng; Gi-Ming Lai; Chia-Lun Chang; Ming-Hung Hu; Wei-Lun Tsai; Yun-Ru Liu; Simon Hsia; Shuang-En Chuang; Tzeon-Jye Chiou; Le-Ming Wang; Jacqueline Whang-Peng; Chih-Jung Yao
Journal:  Mar Drugs       Date:  2020-07-29       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.